$VRAX
Virax Biolabs Group Limited Ordinary Shares
XNAS
Why is VRAX down today? It is at $2.79 (-5.10%), and our scanner flagged it 40 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VRAX spikes, and full due diligence on VRAX — key stats, earnings, dilution and insider activity. Free.
Get free $VRAX alerts the moment volume spikes
Our scanner flagged $VRAX 40 times in the last 30 days. Create a free account to track $VRAX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.79
- Change today
- -5.10%
- Previous close
- $2.94
- 52-week range
- $0.100 – $13.19
- Market cap
- $2M
- Institutional own.
- 3.31%
- Total held
- 5.9%
- Tradeable float
- 750K 94% of shares · after 3% insiders + 3% institutions
- Avg daily volume
- 9.6M
- Next earnings
- Oct 1 · in 32d
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.1x
- 1h
- 0.0x
- 1D
- --
Get free VRAX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $VRAX down today?
Here is the latest on VRAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VRAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystForeign issuer report (6-K), from the latest SEC filing. Read it →Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $VRAX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 1,035,000 new shares (adjusted for the later reverse split) · About $5.0M in size
- About $3.3M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$VRAX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$VRAX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


VRAX stock FAQ
Why is $VRAX down today?
Here is the latest on VRAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VRAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the VRAX stock price today?
VRAX last traded at $2.79, down 5.10% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does VRAX report earnings?
Virax Biolabs Group Limited Ordinary Shares (VRAX) is next expected to report earnings on Thursday, October 1, 2026, about 32 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live VRAX alerts?
The VRAX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VRAX 40 times in the last 30 days.
What exchange is VRAX on?
VRAX (Virax Biolabs Group Limited Ordinary Shares) trades on XNAS, with a market cap of about $2M.
Is VRAX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VRAX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.